Antibody Drug Development Center aims to develop monoclonal antibody drugs with completely independent intellectual property rights by using world-class monoclonal antibody technologies to treat and diagnose cancer and inflammatory diseases. Its mission is to foster independent innovation, improve the capability of monoclonal antibody drug development of our nation, and enhance the competitiveness of the pharmaceutical industry of our nation.